Design and Synthesis of trans-3-(2-(4-((3-(3-(5-Methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro- 1H-3-benzazepine (SB-414796): A Potent and Selective Dopamine D3 Receptor Antagonist (Q44636396)
Jump to navigation
Jump to search
scientific article published on November 6, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Design and Synthesis of trans-3-(2-(4-((3-(3-(5-Methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro- 1H-3-benzazepine (SB-414796): A Potent and Selective Dopamine D3 Receptor Antagonist |
scientific article published on November 6, 2003 |
Statements
1 reference
Design and synthesis of trans-3-(2-(4-((3-(3-(5-methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SB-414796): a potent and selective dopamine D3 receptor antagonist (English)
1 reference
Design and Synthesis of trans-3-(2-(4-((3-(3-(5-Methyl-1,2,4-oxadiazolyl))- phenyl)carboxamido)cyclohexyl)ethyl)-7-methylsulfonyl-2,3,4,5-tetrahydro- 1H-3-benzazepine (SB-414796): A Potent and Selective Dopamine D3 Receptor Antagonist (English)
1 reference
1 reference
Christopher N. Johnson
Geoffrey Stemp
1 reference
Phillip Jeffrey
1 reference
Izzy Boyfield
1 reference
Charlie Reavill
1 reference
Martyn Wood
1 reference
Charles R Ashby Jr
1 reference
Gregor J. Macdonald
Clive L. Branch
Michael S. Hadley
David J. Nash
Alexander B. Smith
Kevin M. Thewlis
Antonio K. K. Vong
Nigel E. Austin
Kim Y. Winborn
Jim J. Hagan
Derek N. Middlemiss
Graham J. Riley
Jeannette M. Watson
Steve G. Parker
Charles R. Ashby
1 November 2003
1 reference
6 November 2003
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference